Supporting equitable access to legal and regulated psychedelic medicine for all Canadians.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.







MAPS Canada is powered by a large and dedicated group of volunteers!

Interested in learning more about scientific research on psychedelics?

Then consider this your invitation to join the MAPS Canada virtual Journal Club.

Each Journal Club session is one hour to ninety minutes long, and features typically two speakers (15 – 20 minutes each) followed by an open Q + A.

8:00 pm ET, the second-to-last Thursday of each month

Meetings are held on Zoom

Anyone with an interest in psychedelic science and research, anywhere in the world, is welcome to attend.


Free public livestream from The Canadian Psychedelic Summit: An Evening with Paul Stamets

August 7, 2022, 8:00 - 10:00 pm PT

As part of the inaugural Canadian Psychedelic Summit, MAPS Canada and Hollyhock are honoured to present a free livestream with Paul Stamets, speaking on psilocybin and neurogenesis.

With the increasing interest in microdosing, what are the implications for age-related neuropathies or neurogenerative diseases? Paul will present compelling evidence that microdosing stacked with other substances may improve neurological health.

Paul Stamets, a speaker, author, mycologist, medical researcher and entrepreneur, is considered an intellectual and industry leader in fungi: habitat, medicinal use, and production. He lectures extensively to deepen the understanding and respect for the organisms that literally exist under every footstep taken on this path of life. His presentations cover a range of mushroom species and research showing how mushrooms can help the health of people and the planet. His central premise is that habitats have immune systems, just like people, and mushrooms are cellular bridges between the two. Our close evolutionary relationship to fungi can be the basis for novel pairings in the microbiome that lead to greater sustainability and immune enhancement.